Effects of bufalin on the proliferation of human choriocarcinoma cells

International Journal of Gynecological Cancer

Volumn 21, Issue 6, 2011, Pages 1105-1109

  Takai, Noriyuki ^a   Ueda, Tami ^a   Ishii, Terukazu ^a   Kira, Naoko ^a   Nishida, Masakazu ^a   Nishida, Yoshihiro ^a   Nasu, Kaei ^a   Narahara, Hisashi ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Bufalin; Cell cycle; Choriocarcinoma

Indexed keywords

BUFALIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CARCINOMA CELL; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN BEWO; CHORIOCARCINOMA; FEMALE; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; BUFANOLIDES; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CHORIOCARCINOMA; FEMALE; FLOW CYTOMETRY; HUMANS; PREGNANCY; UTERINE NEOPLASMS;

EID: 83055178965     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e318218730e     Document Type: Article

References (25)

1. Jones WB, Cardinale C, Lewis JL Jr. Management of the high-risk gestational trophoblastic disease: the Memorial Hospital experience. Int J Gynecol Cancer. 1997;7:27Y33. (Pubitemid 27010014)
2. Berkowitz RS, Goldstein DP, Bernstein MR. Modified triple chemotherapy in the management of high-risk gestational trophoblastic tumors. Gynecol Oncol. 1984;19:173Y181. (Pubitemid 14024343)
3. Surwit EA, Hammond CB. Treatment of metastatic trophoblastic disease with poor prognosis. Obstet Gynecol. 1980;55:565Y570. (Pubitemid 10068252)
4. Krenn L, Kopp B. Bufadienolides from animal and plant sources. Phytochemistry. 1998;48:1Y29. (Pubitemid 28242374)
5. Hong Z, Chen K, Yeung HW. Simultaneous determination of bufadienolides in the traditional Chinese medicine preparation, Liu Shen Wan, by liquid chromatography. J Pharm Pharmacol. 1992;44:1023Y1026.
6. Song H, Guo T, Bi K, et al. Determination of resibufogenin and cinobufagin in heart-protecting musk pill by HPLC. Biomed Chromatogr. 2000;14:130Y132. (Pubitemid 30166795)
7. Morishita S, Shoji M, Oguni Y. Pharmacological actions of 'Kyusin', a drug containing toad venom: cardiotonic and arrhythmogenic effects. Am J Chin Med. 1992;20:245Y246.
8. Numazawa S, Shinoki M, Ito H, et al. Involvement of Na+,K+-ATPase inhibition in K562 cell differentiation induced by bufalin. J Cell Physiol. 1994;160:113Y120. (Pubitemid 24214042)
9. Jing Y, Watabe M, Hashimoto S, et al. Cell cycle arrest and protein kinase modulating effect of bufalin on human leukemia ML1 cells. Anticancer Res. 1994;14:1193Y1198. (Pubitemid 24272589)
10. Masuda Y, Kawazoe N, Nakajo S, et al. Bufalin induces apoptosis and influences the expression of apoptosis-related genes in human leukemia cells. Leuk Res. 1995;19:549Y556.
11. Watabe M, Ito K, Masuda Y, et al. Activation of AP-1 is required for bufalin-induced apoptosis in human leukemia U937 cells. Oncogene. 1998;16:779Y787. (Pubitemid 28076089)
12. Kawazoe N, Watabe M, Masuda Y, et al. Tiam1 is involved in the regulation of bufalin-induced apoptosis in human leukemia cells. Oncogene. 1999;18:2413Y2421. (Pubitemid 29206154)
13. Yeh J-Y, Huang WJ, Kan S-F, et al. Effects of bufalin and cinobufagin on the proliferation of androgen dependent and independent prostate cancer cells. Prostate. 2003;54:112Y124. (Pubitemid 36120327)
14. Takai N, Desmond JC, Kumagai T, et al. Histone deacetylase inhibitors have a profound anti-growth activity in endometrial cancer cells. Clin Cancer Res. 2004;10:1141Y1149. (Pubitemid 38198916)
15. Takai N, Ueda T, Nishida M, et al. Bufalin induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells. Int J Mol Med. 2008;21:637Y643.
16. Rimon G, Bazenet CE, Philpott KL, et al. Increased surface phosphatidylserine is an early marker of neuronal apoptosis. J Neurosci Res. 1997;48:563Y570. (Pubitemid 27276686)
17. Chen Y, Kramer DL, Diegelman P, et al. Apoptotic signaling in polyamine analogue-treated SK-MEL-28 human melanoma cells. Cancer Res. 2001;61:6437Y6444. (Pubitemid 32783249)
18. Johnson DG, Walker CL. Cyclins and cell cycle checkpoints. Annu Rev Pharmacol Toxicol. 1999;39:295Y312. (Pubitemid 29222561)
19. Sherr CJ. G1 phase progression: cyclin on cue. Cell. 1994;79:551Y555.
20. Jones DP, McConkey DJ, Nicotera P, et al. Calcium-activated DNA fragmentation in rat liver nuclei. J Biol Chem. 1989;264:6398Y6403. (Pubitemid 19106722)
21. Trump BF, Berezesky IK. Calcium mediated cell injury and cell death. FASEB J. 1995;9:219Y228.
22. Furaya Y, Lundmo P, Short AD, et al. The role of calcium, pH, and cell proliferation in the programmed (apoptotic) death of a drogen-independent prostatic cancer cells induced by thapsigargin. Cancer Res. 1984;44:3522Y3529.
23. Panesar NS. Bufalin and unidentified substance(s) in traditional Chinese medicine cross-react in commercial digoxin assay. Clin Chem. 1992;38:2155Y2156.
24. Bhuiyan MB, Fant ME, Dasgupta A. Study on mechanism of action of Chinese medicine Chan Su: dose-dependent biphasic production of nitric oxide in trophoblastic BeWo cells. Clin Chim Acta. 2003;330:179Y184. (Pubitemid 36287646)
25. Xia X, Hou F, Li J, et al. Two novel proteins bind specifically to trichosanthin on choriocarcinoma cell membrane. J Biochem. 2006;139:725Y731. (Pubitemid 43973919)